Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)








2019 CDC U.S. TB Elimination Champions						Print
																Related Pages
										Collaborating with public health partners, health care providers, and community organizations
Return to TB Elimination ChampionsOpen All Close AllFlorida Department of Health, Duval CountyTo protect the homeless population, the Florida Department of Health – Duval County (DOH-Duval) provides TB testing to all persons seeking to stay at one of the 4 large shelters in town.
DOH-Duval’s shelter card system has proven to be an exceptional surveillance initiative that is effective at identifying and reducing the risk of transmission of TB in local homeless shelters and at reducing the risk of progression to active disease through successful treatment of latent TB infection with 3HP.
Florida Department of Health, Duval CountyFront Row (left to right): Cheryl Elam, RN; Patricia Hunt, LPN; Anne Mance, RN; June Robinson.
Back Row (left to right): Penny Dickerson; Darrell Sheffield; Tawanda Washington, ADON; Ashley Donnelly; Antonio James; John Eledge; Sheri Davis.
Not pictured: Catherine Abston, Bridgett Austin, Frederick Fiore, Kiszzie Jones, Jemima PayneKate O’Brien, We Are TB, TB SurvivorA servant leader in We Are TB, the growing community of U.S.‐based TB survivors, Kate personifies the heart of an advocate with her tireless efforts to raise awareness, her unparalleled energy to confront the stigma associated with this disease, and her ability to nurture others as they insert their voices into advocacy efforts and peer‐to-peer support.
“It’s Time” to reduce stigma and listen to patients and survivors!  “It’s Time” to engage in TB advocacy efforts for a TB Free USA!
Kate O’Brien and her son Jimmy on the NYC Times Square Jumbotron. Space secured by NTCA.Kate O’Brien and her son Jimmy on the NYC Times Square Jumbotron. Space secured by NTCA.In Congressman Donald Payne Jr.’s New Jersey office. From left to right: Arpita Jindani (GTBI); Dona Miller (Lattimore Clinic); Kate O’Brien (We are TB); Congressman Donald Payne Jr.; Judy Thomas (Lattimore Clinic); Patricia Woods (Lattimore Clinic); Mark Wolman (GTBI)In Congressman Donald Payne Jr.’s New Jersey office. From left to right: Arpita Jindani (GTBI); Dona Miller (Lattimore Clinic); Kate O’Brien (We are TB); Congressman Donald Payne Jr.; Judy Thomas (Lattimore Clinic); Patricia Woods (Lattimore Clinic); Mark Wolman (GTBI)Kate O’Brien speaking at a TB event.Kate O’Brien speaking at a TB event.Laura Smock, MPH, Epidemiologist, Massachusetts Department of Public HealthPhoto Caption: Laura Smock’s dedicated work to end TB is reflected in her poster, “Evaluation of Contact Examination in Massachusetts.”Laura Smock’s dedicated work to end TB is reflected in her poster, “Evaluation of Contact Examination in Massachusetts.”
Laura Smock and her team developed strategies to improve TB contact investigations by building relationships with three high-morbidity cities of focus, developing new materials for large contact investigations, and improving the surveillance database to easily identify the highest priority cases for contact investigation.Majuro, Republic of the Marshall Islands TB ProgramPhoto Caption: Community worker Joel Bujen and Nurse Adela Sibok-Nakamura prepare 3HP for community distribution in Majuro in June, 2018.Community worker Joel Bujen and Nurse Adela Sibok-Nakamura prepare 3HP for community distribution in Majuro in June, 2018.
The Marshall Islands TB Program is challenged by the workload, but is proud to be completing an ambitious project focused on both latent TB infection and active TB disease.  The program has a new physician, new nurses and community workers, new TB protocols, and has reorganized to prioritize TB prevention for the future.  The program is on the voyage to TB elimination!
In addition to finding and treating more than 300 cases of TB, the Majuro TB program delivered over 40,000 doses of TB prevention for the mass prevention program this summer.  Program staff prepared and implemented TB mass screening for 22,000 residents, delivering prevention to more than 3,000 individuals.
It’s Time to end TB in Majuro, Marshall Islands!Daria Szkwarko, DO, MPH, Assistant Professor, Brown UniversityPhoto Caption: Daria Szkwarko (center) Right, top to bottom Pat Iyer, Massachusetts Department of Public Health Andy Tibbs, Massachusetts Department of Public Health Danielle Fitzsimmons-Pattison and Rebecca Thal, Family Health Center of Worcester Victoria Chavez, ECHO Institute Michael Argényi, University of Massachusetts Medical SchoolDaria Szkwarko during a Latent TB Infection-ECHO session
Dr. Szkwarko is the Latent TB Infection-ECHO course director and facilitator, with participants from community health centers in Massachusetts and ‘hub’ experts. She champions building capacity for latent TB infection testing and treatment in primary care providers.  The curriculum guides core learning through the cascade of care, and multi-disciplinary teams join monthly sessions. Dr. Szkwarko is a great mentor, teacher, and advocate, and participants have opportunities to learn from peers.
It’s time to strengthen TB education and awareness among health care providers!Monroe County, New York, Department of Public Health TB ControlPhoto Caption: The photo is taken at a college campus screening. All international students entering in the fall semester are screened and offered treatment for TB. Front row: Patricia Manuse, Sophia Worrell-Brown, Cindy Collins Back row: Abdirahman Yussuf, Renee Jenkins, Jennifer Ritter, Jazzlyn Ivery-Robinson, Archie Robinson, Leannah Grimsley, Shane Gurnee, Chittadaphone Phouthavong, Sandra Santana, Juireith Donko-Hanson, David BovardFront row: Patricia Manuse, Sophia Worrell-Brown, Cindy Collins; Back row: Abdirahman Yussuf, Renee Jenkins, Jennifer Ritter, Jazzlyn Ivery-Robinson, Archie Robinson, Leannah Grimsley, Shane Gurnee, Chittadaphone Phouthavong, Sandra Santana, Juireith Donko-Hanson, David Bovard
Monroe County, NY, welcomes refugees from areas where TB is endemic. Roughly 600-900 refugees from all over the world arrive in Rochester, NY annually (data through 2017). Refugees are screened at Monroe County, Department of Public Health TB Control (MCDPH) on arrival and treated for active TB disease or latent TB infection. By testing and treating incoming international students for TB, the program has prevented exposure to TB disease and the potential for a large contact investigation on college campuses in Monroe County.  Through use of technology, collaboration, and partnerships, the MCDPH is working hard to eliminate TB in the Upstate New York region. “It’s Time to End TB!”Neha Shah, MD, MPH, Project Director, TB Free CaliforniaFrom left to right: Mallory Schmitt, Clinicas de Salud del Pueblo (CSP), Imperial County, California; Neha Shah, Project Director, TB Free California, California Department of Public Health; Marti Brentnall, TB Prevention Coordinator, San Diego County Health and Human Services;Tessa Mochizuki, Prevention Epidemiologist, TB Free California  Photo Caption: TB partners and products made for Clinicas de Salud del Pueblo (CSP), Imperial County.From left to right: Mallory Schmitt, Neha Shah, Marti Brentnall, Tessa Mochizuki
Neha Shah is Project Director of TB Free California. Her visionary strategies, perseverance and unbridled optimism have led TB Free California to accomplish great strides.
The TB Free California project promotes TB awareness among providers and at-risk populations, and builds providers’ ability to recognize and treat latent TB infection. Collaboration with several sites in California has helped to increase latent TB infection testing and treatment, and to integrate testing and treatment steps into routine primary care.
It’s time to strengthen TB education and awareness among health care providers!Dr. Greg Stern, Health Officer for Whatcom County Public HealthPhoto Caption: Dr. Greg Stern urges clinicians to “Think TB”.Dr. Greg Stern urges clinicians to “Think TB”.
Dr. Greg Stern believes that “It’s Time for Clinicians to Think TB.” Dr. Stern engages providers through humor and insight on TB ECHO and advocates for improvements in TB care with other Washington State Health Officers. Whatcom County health department staff add that he focuses on the highest standards of care and makes program improvements to prioritize patient outcomes, and maximize appropriate use of electronic directly observed therapy (eDOT).
Dr. Stern is quick to credit the team of nurses he works with for their shared success.  Together, they work towards eliminating TB by providing patient-centered care, engaging patients as partners in their care and in preventing transmission of TB to others, and coordinating with other medical care providers and state and county public health partners.We Are TB, TB Survivor NetworkWe are TB
Over the past 3 years, We Are TB has collaborated with the National Tuberculosis Controllers Association to support TB survivors.
We Are TB is a growing TB survivor network that is working towards better TB diagnostics, treatment regimens, and support to U.S.-based public health programs. The network provides an informative and supportive community for patients and survivors where they can share common struggles, triumphs, and fears.  Survivors participate in advocacy work, and share personal stories to drive change at the local, state, and national level.
Some We Are TB members have participated in CDC’s TB Personal Stories to talk about their personal experiences with TB and help raise awareness about TB in the United States.
It’s time to end stigma. It’s time to end TB!
							
					
							Last Reviewed:  March 14, 2019						Source: 	Division of Tuberculosis Elimination
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue